HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) An erratum has been published Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kang, W. J. Articles by Lee, D. S. Search for Related Content PubMed PubMed Citation Articles by Kang, W. J. Articles by Lee, D. S.

Tissue Distribution of ¹⁸F-FDG-Labeled Peripheral Hematopoietic Stem Cells After Intracoronary Administration in Patients with Myocardial Infarction

¹ Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea; and ² Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

Correspondence: For correspondence or reprints contact either of the following: Dong Soo Lee, MD, PhD, Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yeongeon-dong, Jongno-gu, Seoul 110-744, Korea.E-mail: dsl{at}plaza.snu.ac.kr June-Key Chung, MD, PhD, Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yeongeon-dong, Jongno-gu, Seoul 110-744, Korea. E-mail: jkchung{at}plaza.snu.ac.kr

Adult stem cell therapy is expected to improve left ventricular function in patients with myocardial infarction. Because of the low risk of arrhythmia and the maximal concentration at the target tissue, intracoronary infusion of stem cells is preferred. The aim of this study was to investigate the homing and tissue distribution of intracoronary injected peripheral hematopoietic stem cells labeled with ¹⁸F-FDG. Methods: Seventeen patients with myocardial infarction were included as the intracoronary injection group (14 males, 3 females; age, 58 ± 12 y). Three patients underwent intravenous stem cell injection as the intravenous injection group (3 males, 0 females; age, 50 ± 20 y). After mobilization with granulocyte colony-stimulating factor (G-CSF), peripheral stem cells were collected by means of apheresis. ¹⁸F-FDG labeling of stem cells was performed for 40 min with gentle intermittent mixing at 37°C. The mean labeling efficiency was 72% (range, 46%–95%), and 44.4–175 MBq (1.2–5 mCi) of ¹⁸F-FDG-labeled stem cells were injected via an intracoronary catheter after stenting in infarct-related arteries. PET/CT images were obtained with a 3-dimensional acquisition mode 2 h after intracoronary infusion. Results: Two hours after intracoronary infusion, 1.5% (range, 0.2%–3.3%) of injected stem cells accumulated at the infarcted myocardium. Outside of the myocardium, spleen, liver, bladder, and bone marrow showed a high stem cell accumulation. The delayed image of a patient up to 20 h showed a prolonged residence of stem cells at the myocardium. Intravenous injection of stem cells showed a high initial lung uptake with no myocardial activity. Conclusion: We have shown that ¹⁸F-FDG-labeled stem cell PET could be used to assess the tissue distribution and to measure the amount of stem cells at a target tissue. ¹⁸F-FDG-labeled stem cell PET can be used to measure and optimize the amount of stem cells injected.

Key Words: stem cell therapy • ¹⁸F-FDG PET • in vivo cell tracking

This article has been cited by other articles:

				M.-S. Kim, C.-S. Lee, J. Hur, H.-J. Cho, S.-I. Jun, T.-Y. Kim, S.-W. Lee, J.-W. Suh, K.-W. Park, H.-Y. Lee, et al. Priming With Angiopoietin-1 Augments the Vasculogenic Potential of the Peripheral Blood Stem Cells Mobilized With Granulocyte Colony-Stimulating Factor Through a Novel Tie2/Ets-1 Pathway Circulation, December 1, 2009; 120(22): 2240 - 2250. [Abstract] [Full Text] [PDF]

				J. K. Willmann, R. Paulmurugan, M. Rodriguez-Porcel, W. Stein, T. J. Brinton, A. J. Connolly, C. H. Nielsen, A. M. Lutz, J. Lyons, F. Ikeno, et al. Imaging Gene Expression in Human Mesenchymal Stem Cells: From Small to Large Animals1 Radiology, July 1, 2009; 252(1): 117 - 127. [Abstract] [Full Text] [PDF]

				J. K. Willmann, R. Paulmurugan, M. Rodriguez-Porcel, W. Stein, T. J. Brinton, A. J. Connolly, C. H. Nielsen, A. M. Lutz, J. Lyons, F. Ikeno, et al. Imaging Gene Expression in Human Mesenchymal Stem Cells: From Small to Large Animals Radiology, April 14, 2009; (2009) 2513081616. [Abstract] [Full Text]

				H.-J. Kang and H.-S. Kim Safety and efficacy of intracoronary infusion of mobilized peripheral blood stem cell in patients with myocardial infarction: MAGIC Cell-1 and MAGIC Cell-3-DES-trials Eur. Heart J. Suppl., December 1, 2008; 10(suppl_K): K39 - K43. [Abstract] [Full Text] [PDF]

				Y. Zhang, S. Thorn, J. N. DaSilva, M. Lamoureux, R. A. deKemp, R. S. Beanlands, M. Ruel, and E. J. Suuronen Collagen-Based Matrices Improve the Delivery of Transplanted Circulating Progenitor Cells: Development and Demonstration by Ex Vivo Radionuclide Cell Labeling and In Vivo Tracking With Positron-Emission Tomography Circ Cardiovasc Imaging, November 1, 2008; 1(3): 197 - 204. [Abstract] [Full Text] [PDF]

				B. Doyle, B. J. Kemp, P. Chareonthaitawee, C. Reed, J. Schmeckpeper, P. Sorajja, S. Russell, P. Araoz, S. J. Riederer, and N. M. Caplice Dynamic Tracking During Intracoronary Injection of 18F-FDG-Labeled Progenitor Cell Therapy for Acute Myocardial Infarction J. Nucl. Med., October 1, 2007; 48(10): 1708 - 1714. [Abstract] [Full Text] [PDF]